AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N92020C00021CERES NANOSCIENCES, INC.
Overview
Award facts
- Net obligations
- $6.57M
- $6,574,000of $6.57M potential value
- Outlays (paid to date)
- $6.57M
- $6.57M paid of $6.57M obligated$6,574,000
- Period of performance
- Aug 28, 2020 to May 31, 2021
- Ended
- Modifications
- 4
- Latest action Mar 15, 2023
- Contract type
- Definitive contract
- PIID 75N92020C00021
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RADX TECH - CERES NANOSCIENCE INC NANOTRAP PARTICLE MANUFACTURING
Dates and value
- Award date
- Signed on Aug 28, 2020
- Potential end of performance
- Aug 26, 2021
- Current value
- $6,574,000Base and exercised options
- Potential value (if all options are exercised)
- $6,574,000
Obligations by fiscal year of action
- FY2021: $3,974,000
- FY2020: $2,600,000
Total across 2 fiscal years: $6,574,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 15, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationMANASSAS, VA
UEIGL6HXTK992Y4
CAGE code6KXK0
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCERES NANOSCIENCES, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded from
- National institute of biomedical imaging and bioengineering (0898)Program activities075-0898Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Manassas, Prince William County, Virginia 20110-2214
- Congressional district (place of performance)
- VA-10As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- Q301MEDICAL- LABORATORY TESTING (service)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Urgency (FAR 6.302-2)URG
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Major program
- Rapid acceleration of diagnostics (RADX)
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 28, 2020Base obligation at award: $2,600,000
- Latest action
- Mar 15, 2023 — CloseoutModification P00004; administrative: no change in scope or value
- Latest substantive action
- Oct 13, 2020 — Letter contract definitizedModification P00001; obligation change +$3,974,000
- Actions by type
- Base award1
- Other administrative action2
- Letter contract definitized1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N920
- Treasury accounts
- 075-X-0898-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- P: Emergency P.L. 116-139
- COVID-19 supplemental obligations
- $6,574,000
- COVID-19 supplemental outlays
- $6,574,000